Efectos neuroprotectores del ácido araquidónico y del ácido docosahexaenoico en las etapas extremas de la vida: Una visión integradora

Orellana, Paula; Valenzuela, Rodrigo; Valenzuela, Alfonso; Morales, Gladys I.
Rev. chil. nutr ; 45(1): 80-88, 2018. graf
Artículo en Español | LILACS | ID: biblio-899858

Documentos relacionados

  1. Diagnostic criteria in dementing illness. What's new?
  2. The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications.
  3. Alzheimer's disease: From immunotherapy to immunoprevention.
  4. Cognitive rehabilitation for people with mild to moderate dementia.
  5. The AD odyssey 2023: Tales of single cell.
  6. The Role of Cellular Defense Systems of Ferroptosis in Parkinson's Disease and Alzheimer's Disease.
  7. Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles.
  8. Dietary DHA and health: cognitive function ageing.
  9. Glucose-oxygen coupling can serve as a biomarker for neuroinflammation-related genetic variants.
  10. Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.